Sleep medicine:
one field, many front doors

At a glance

Every specialty on this site involves a trade, and sleep medicine’s is unusually gentle: you give up procedures, hospital acuity, and a large pay premium, and you get a mostly outpatient practice built on pattern recognition and long-term coaching, one of the most controllable lives in medicine, and a field whose patient population — the enormous, mostly undiagnosed obstructive-sleep-apnea population — is not going anywhere. The honest caution is the money: for an internist, the added fellowship year rarely pays for itself. Choose sleep for the work and the life, and go in clear-eyed about who certifies you and how the field is being reshaped.

What it involves

Sleep medicine physicians diagnose and manage the whole range of sleep–wake disorders. The bread and butter is obstructive sleep apnea (OSA), but the field also covers insomnia, narcolepsy and idiopathic hypersomnia, restless legs syndrome and periodic limb movement disorder, REM and non-REM parasomnias, circadian rhythm disorders (shift work, delayed sleep phase, jet lag), and sleep-related hypoventilation and central sleep apnea. Patients run from young adults with narcolepsy to older adults with complex apnea layered on cardiopulmonary disease. The work is overwhelmingly cognitive and largely outpatient: overnight studies are run by technologists, and the physician interprets them the next day rather than being present in the lab.

A day-to-day mix (illustrative, not a benchmark)

A dedicated sleep physician’s week is roughly, as an example rather than a universal rule: about half in outpatient clinic (new consults and follow-ups — OSA on PAP, a narcolepsy work-up, restless legs, an insomnia patient headed toward CBT-I, a circadian problem); about a quarter to a third interpreting studies (in-lab polysomnograms, home sleep apnea tests, latency and wakefulness tests, actigraphy); and the remainder in administration — PAP adherence review, durable-medical-equipment (DME) coordination, and prior authorizations. Call is minimal. The exact split shifts with your setting and base training, but the shape — clinic-heavy, interpretation-rich, admin-real, call-light — is consistent.

The pathway, at a glance

The training route is simpler than the prose around it suggests:

How you trained shapes how you practice: pulmonologists fold sleep into a broader pulmonary/critical-care practice and dominate the full-time sleep job market; neurologists gravitate toward narcolepsy, hypersomnia, restless legs, and parasomnias; ENT physicians focus on surgical OSA; psychiatrists emphasize insomnia and behavioral sleep medicine. For an internist without pulmonary training, sleep is usually a standalone outpatient practice or an add-on to primary care or hospital medicine.

Who certifies you

This is the fact most often gotten wrong. Sleep medicine is not owned by one board. The certifying examination is jointly developed by six ABMS member boards — ABIM, the American Board of Family Medicine (ABFM), the American Board of Pediatrics (ABP), the American Board of Psychiatry and Neurology (ABPN), the American Board of Otolaryngology–Head and Neck Surgery (ABOHNS), and the American Board of Anesthesiology (ABA). ABIM administers the single exam, but each candidate holds the certificate with their own board. Of the 7,816 physicians ever certified, the ABIM 2026 Sleep Medicine Diplomate Report puts the breakdown at 61.9% ABIM, 23.0% ABPN, 5.9% ABP, 4.9% ABFM, 3.9% ABOHNS, and 0.3% ABA — internal medicine and the neurologic/psychiatric specialties together account for roughly five in six sleep physicians⁵.

Competitiveness

Frame this carefully, because sleep medicine is not the wide-open door some short fellowships are. It is less competitive than the procedural subspecialties, and a solid, committed IM resident is very likely to match — but it genuinely fills. In the 2026 appointment-year Match, sleep offered 222 certified positions across 104 programs and filled 208 (93.7%); of 266 applicants who ranked a sleep program, 236 preferred it, 132 (49.6%) matched their first-ranked program, and 43 (16.2%) went unmatched, with only 10 programs finishing with an unfilled position². That 93.7% is what sets sleep apart from its one-year-fellowship neighbors: among the one-year band in 2026, sleep fills at 93.7%, hospice and palliative medicine at 79.5%, addiction medicine at 63.8%, and geriatric medicine at just 38.9%. Sleep is the one-year fellowship that reliably fills — because it recruits from a wide, multi-specialty pool and its lifestyle reputation is well earned.

The trend is slow, uneven growth rather than a steady climb: matches went 179, 178, 188, 207, 208 across the 2022–2026 appointment years (dipping in 2023), and the fill rate has wobbled — 92.7%, 88.6%, 88.3%, 95.0%, 93.7%²⁷. Because most positions fill and a few reliably do not, the successful-applicant profile is forgiving: a residency in good standing, genuine interest (a sleep elective and a supportive letter help), and passing board performance are usually enough. This is one of the few fellowships where a solid, unremarkable application from an IM resident is very likely to succeed.

Skills & personality

Sleep medicine rewards a specific temperament. Much of the value you add is data interpretation — reading polysomnograms and home studies, comfortable with waveform data and scoring rules and the nuances that separate central from obstructive events or catch a REM-sleep behavior disorder. If you liked physiology and pattern recognition and disliked the adrenaline of acute care, that is a genuine signal.

The rest is chronic-disease management and persuasion. Most sleep conditions are chronic and behavioral, and success hinges less on a dramatic cure than on getting a patient to tolerate PAP, engage in CBT-I, or stick with a plan over months and years. That takes patience, communication, and coaching — plus a tolerance for systems work: sleep labs, home-testing logistics, DME coordination, and prior authorizations reward physicians who can manage workflows and reimbursement, and frustrate those who cannot. The field mixes pulmonary, neurologic, psychiatric, and ENT thinking, so interdisciplinary comfort helps.

Who tends to be unhappy? Physicians who crave procedures, acuity, or hospital intensity; those who resent administrative and insurance friction; and those who find repetitive study interpretation or long-haul adherence counseling monotonous. The work is calm by design — if calm reads to you as dull, this is not your field.

Lifestyle & balance

The schedule is a genuine draw, and it is not overstated — but treat it as one trade-off of the work, not the identity of the field. Hours are predictable and largely daytime: clinic and study-reading are schedulable, and there is little emergent work. Call is minimal — unlike pulmonary/critical care, a pure sleep practice has little or no overnight or ICU call, which is precisely why some pulmonologists deliberately shift toward sleep later in their careers. Sleep is also among the most telemedicine-amenable fields in medicine, which supports part-time and flexible arrangements. Lifestyle varies by how you trained: a pulmonologist who keeps a foot in critical care keeps that call, while a neurologist or internist doing predominantly sleep enjoys the calmest schedule in the building.

Compensation

The most important structural fact about sleep-medicine pay is that there is no clean standalone figure, because sleep is almost always practiced blended with a base specialty — the surveys fold sleep pay into pulmonology, neurology, psychiatry, or internal medicine. So the honest way to anchor your expectations is to your base specialty: a pulmonologist-sleep physician earns near pulmonology pay (Doximity put pulmonology around $425,700 in 2024 data), while a dedicated sleep-only internist tends toward the general-internal-medicine end (around $326,116 in the same report)³. The added fellowship year does not, by itself, command a large premium, and the proprietary benchmark surveys do not publish a standalone, independently verifiable sleep median⁸.

What drives the income: clinic evaluation-and-management visits (the bulk of most sleep physicians’ work), efficient high-throughput interpretation of sleep studies, and — in ownership models — sleep-lab and home-testing facility economics. A generation ago, in-lab polysomnography reimbursed richly and labs needed physicians to read the volume; that tailwind has weakened as payers pushed toward far cheaper home sleep apnea testing, compressing lab margins even as clinical demand grows.

Intellectual scope & the GLP-1 shift

Sleep medicine is cognitively rich but procedurally light. The core “procedure” is interpretation — polysomnograms, home tests, latency and wakefulness studies, actigraphy — paired with therapy titration and behavioral and pharmacologic management. The clinical variety is genuine: an internist-trained sleep physician may in one clinic day manage severe OSA on complex PAP, work up a young patient for narcolepsy, adjust restless-legs pharmacotherapy, steer an insomnia patient toward CBT-I, and untangle a shift worker’s circadian problem. The field also intersects with wearable and consumer sleep technology, AI-assisted study scoring, and remote monitoring.

The most newsworthy development is pharmacologic. In December 2024 the FDA approved tirzepatide (Zepbound) as the first medication for moderate-to-severe OSA in adults with obesity⁹, on the strength of the SURMOUNT-OSA program: two trials totaling 469 participants in which tirzepatide reduced the apnea-hypopnea index by about 25–29 events per hour, roughly 20–24 more than placebo, alongside substantial weight loss¹⁰. This is the first time a drug, rather than a device or surgery, has carried an OSA indication.

What it means for the field — as scenarios, not a settled outcome (as of mid-2026). The prevalence and the treatment mix are both moving, so hold the forecast loosely and revisit it when reimbursement and guidelines change:

• The durable, uncontested fact: OSA is highly prevalent and the large majority of cases go undiagnosed, so demand for the field’s expertise is durable regardless of which prevalence number you accept. (A 2025 estimate of 83.7 million US adults / 32.4% is at the high end, uses broad criteria, and has industry-affiliated authors — read it with that in mind¹¹.)
• Likely scenario: the treatment toolkit diversifies beyond PAP — GLP-1-class weight-loss therapy now, plus hypoglossal nerve stimulation co-managed with ENT¹² — and the work shifts from “fit a CPAP” toward diagnosing, risk-stratifying, and managing a larger, more complex treated population. The specialty does not shrink; its center of gravity moves.
• The variable to watch: payer coverage of GLP-1s for OSA, home-testing reimbursement, and society guidelines — these, not the science, will determine how the economics actually land. Re-check them before you build a plan on today’s picture.

Job market & career arc

For an internist, the single most important job-market fact is this: a 100%-sleep clinical job is hard to find outside academia unless you are pulmonary-trained. Sleep is most often combined with a base specialty, so the realistic models sort as follows:

Demand is broad and durable, driven by the large, mostly undiagnosed OSA population; supply grows slowly (ABIM alone newly certified 119 in 2025)⁵. The workforce is unevenly distributed — a 2023 analysis found that of 27 sleep physicians identified among 44,199 clinicians who completed federal HRSA workforce programs, none practiced in a shortage area and one practiced rurally (a small, illustrative denominator)¹³. Capacity clusters in urban academic centers, and that maldistribution, combined with sleep’s strong telemedicine fit, is where the openings and recruitment incentives concentrate.

The career arc, honestly. Sleep is one of the most durable and off-ramp-friendly lives in medicine — cognitive, outpatient, non-strenuous, and telemedicine-ready, so it scales gracefully to part-time and later career. It is the classic destination for pulmonologists stepping back from ICU call, and a natural home for a second, non-clinical domain (sleep-technology and AI-scoring industry roles, telehealth companies, informatics, lab medical direction). Job security is excellent throughout — but for an internist the field is chosen for the work and the schedule, not a pay premium, and a fully dedicated sleep job usually means either academia or a pulmonary base.

IMG considerations

If you are an international medical graduate, this is genuinely good news. Sleep medicine is notably IMG-central: per the ABIM 2026 Sleep Medicine Diplomate Report, 52% of ABIM-certified sleep specialists are IMGs, against 43% US/Canadian graduates — and IMGs are 37% of ABIM subspecialty diplomates overall, so sleep draws on IMGs distinctly harder than the average subspecialty⁵. The Match agrees: IMGs took 86 of the 208 sleep positions filled in 2026 (41.3%), against 29.5% across the SMS². The wide multi-specialty pool, modest competitiveness, and durable demand make sleep an accessible, strategically sensible subspecialty for an IM-bound IMG. (Two companion analyses take up the wider questions: whether international graduates take US graduates' spots, and the H-1B for physicians in training; practical planning lives on the IMG guide.)

Frame the mechanics honestly. Matching into sleep is achievable; the harder parts are visa sponsorship and the compensation trade. On visas, sponsorship is set program by program: J-1 through ECFMG’s Exchange Visitor Sponsorship Program is the standard training route, and many programs sponsor J-1 only and decline H-1B while others do both — confirm each program’s stance early¹⁴. On a J-1, plan around the two-year home-residency requirement and the Conrad 30 waiver — but note that sleep’s need concentrates in urban centers more than fields whose shortage blankets rural America, so the waiver geography is real but less abundant, and each waiver job must be verified.

Eligibility follows the usual package: a valid ECFMG certificate, completion of a US ACGME-accredited IM residency, ABIM internal-medicine certification, and evidence of genuine interest in sleep — a sleep elective, a study-interpretation experience, or a small QI project. For an IM-bound IMG who likes physiology, pattern recognition, and behavioral coaching and who values schedule control, sleep medicine is one of the more attainable and welcoming subspecialty doors in US internal medicine.

Bottom line

Consider sleep medicine if you enjoy waveform interpretation, chronic-disease management, and behavioral coaching; you want a mostly outpatient, cognitive practice with predictable daytime hours, minimal call, and strong telemedicine potential; you want a short, one-year fellowship with a high probability of matching; you are an IMG seeking an accessible, in-demand subspecialty; or you are a pulmonologist or neurologist wanting to diversify or step back from call-heavy work. It is a rational, low-opportunity-cost credential for an internist who genuinely likes sleep and values schedule control over maximizing income.

It may not fit if income is a primary driver — for an internist the added year rarely pays for itself, and a busy hospitalist commonly out-earns a sleep-only internist; if you want procedures, acuity, or inpatient variety; if you have no patience for prior authorizations and DME administration; or if you need a fully dedicated sleep job without pulmonary training, which is scarce outside academia.

A last mentor’s note: sleep medicine is a field to choose for the work and the life, with eyes open on two things — that your certificate comes from your own board (and that the “American Board of Sleep Medicine” is not that board), and that the economics are shifting as GLP-1 therapy and cheaper home testing reshape how the work is done and paid. Find a sleep physician at your program, sit with them for a clinic and a morning of study reads, and ask whether they would choose it again. If the calm, cognitive rhythm of the work appeals to you and the modest pay does not deter you, this is a genuinely good life in medicine.

References

1. American Board of Internal Medicine. (n.d.). Sleep medicine certification policies. https://www.abim.org/certification/policies/internal-medicine-subspecialty-policies/sleep-medicine/ 12-month ACGME fellowship after IM residency and ABIM internal-medicine certification; the exam is co-sponsored by six ABMS boards and each candidate is certified by their own board. ↩₁ ↩₂
2. National Resident Matching Program. (2026). Results and data: Specialties Matching Service, 2026 appointment year. https://www.nrmp.org/match-data/ Sleep medicine: 222 positions across 104 programs, 208 filled (93.7%), 10 programs with an unfilled position; 266 applicants ranked, 236 preferred, 132 (49.6%) matched first choice, 43 (16.2%) unmatched. Five-year fill series wobbled: 92.7%, 88.6%, 88.3%, 95.0%, 93.7%. IMGs took 86 of 208 filled positions (41.3%), vs 29.5% across the SMS. Match conducted December 3, 2025. ↩₁ ↩₂ ↩₃ ↩₄
3. Doximity. (2025). Physician compensation report 2025 (2024 data). https://www.doximity.com/reports/physician-compensation-report/2025 Self-reported/modeled survey. Base-specialty anchors for blended sleep practice: pulmonology about $425,700; general internal medicine about $326,116. There is no clean standalone "sleep medicine" figure because sleep pay is folded into the base specialty. ↩₁ ↩₂
4. Accreditation Council for Graduate Medical Education. (2025). Program requirements for graduate medical education in sleep medicine (reformatted). https://www.acgme.org/globalassets/pfassets/programrequirements/2025-reformatted-requirements/520_sleepmedicine_2025_reformatted.pdf One-year fellowship structure. ACGME reformatted its requirements in 2025 — read the current version. ↩
5. American Board of Internal Medicine. (2026). Sleep medicine diplomate report 2026. https://www.abim.org/media/0excguwk/sleep-medicine-diplomate-report-2026.pdf Ever-certified breakdown (N=7,816): 61.9% ABIM, 23.0% ABPN, 5.9% ABP, 4.9% ABFM, 3.9% ABOHNS, 0.3% ABA. 52% of ABIM-certified sleep specialists are IMGs vs 43% US/Canadian graduates (IMGs are 37% of ABIM subspecialty diplomates overall). ABIM newly certified 119 in 2025; certificates first issued 2007. ↩₁ ↩₂ ↩₃
6. American Board of Sleep Medicine. (n.d.). About ABSM; credential verification. https://absm.org/about/ ABSM administered physician certification 1978–2006; ABMS member boards took over the exam beginning 2007. ABSM still maintains and verifies the lifetime pre-2007 "Diplomate, ABSM" physician credential and recertifies Registered Sleep Technologists through 2032, but no longer certifies new sleep physicians. ↩
7. American Academy of Sleep Medicine. (2025). Match day fills the highest number of sleep medicine fellowship positions. https://aasm.org/match-day-fills-the-highest-number-of-sleep-medicine-fellowship-positions/ 104 programs, 222 positions, 208 filled (the most AASM has recorded; table runs back to 150 in 2018 and 165 in 2021). AASM reports 38 applicants unmatched vs NRMP’s 43 — different denominators (the 236 who preferred sleep vs the 266 who ranked it); this page uses NRMP’s figures and does not mix them. ↩
8. MGMA. (2025). Provider compensation data. Subscription-gated, not reproduced here. Does not publish a standalone, independently verifiable sleep-medicine median; self-reported aggregators exist but draw on small, drifting samples and are directional only. ↩
9. U.S. Food and Drug Administration. (2024, December 20). FDA approves first medication for obstructive sleep apnea. https://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apnea Tirzepatide (Zepbound) approved for moderate-to-severe OSA in adults with obesity, with a reduced-calorie diet and increased physical activity — the first drug, rather than a device or surgery, to carry an OSA indication. ↩
10. Malhotra, A., et al. (2024). Tirzepatide for the treatment of obstructive sleep apnea and obesity. New England Journal of Medicine. https://pmc.ncbi.nlm.nih.gov/articles/PMC11598664/ SURMOUNT-OSA (NCT05412004): two trials, 469 participants (one not on PAP, one on PAP); tirzepatide reduced the apnea-hypopnea index by about 25–29 events/hour, roughly 20–24 more than placebo, with substantial weight loss. ↩
11. Sönmez, S., et al. (2025). Unmasking obstructive sleep apnea: Estimated prevalence and impact in the United States. Respiratory Medicine, 248, 108348. https://pubmed.ncbi.nlm.nih.gov/40957495/ Estimated 83.7 million US adults (about 32.4% aged 20+) had OSA in 2024 — a high-end figure using broad diagnostic criteria. Three authors are employees of Apnimed, Inc., which the paper states is developing OSA drugs; read the estimate with that in mind. The durable, uncontested fact is that OSA is highly prevalent and mostly undiagnosed. ↩
12. Strollo, P. J., et al. (2014). Upper-airway stimulation for obstructive sleep apnea. New England Journal of Medicine. https://pubmed.ncbi.nlm.nih.gov/24401051/ STAR trial — the evidence base for FDA-approved hypoglossal nerve stimulation, an implantable device therapy co-managed with ENT. ↩
13. Singh, J., et al. (2023). Shortage of sleep medicine specialists in federally qualified health centers: An illustrative example of differential access to care. Journal of Clinical Sleep Medicine. https://pmc.ncbi.nlm.nih.gov/articles/PMC10545989/ Of 27 sleep physicians identified among 44,199 clinicians who completed HRSA workforce programs (2011–2021), none practiced in a Health Professional Shortage Area or Medically Underserved Area/Population and one practiced rurally. A small denominator the authors call illustrative. ↩
14. Educational Commission for Foreign Medical Graduates. (n.d.). Exchange Visitor Sponsorship Program (J-1): General information. https://www.ecfmg.org/evsp/applying-general.html ↩
15. Restriction on Entry of Certain Nonimmigrant Workers, Proclamation No. 10973. (2025, September 24). Federal Register. https://www.federalregister.gov/documents/2025/09/24/2025-18601/restriction-on-entry-of-certain-nonimmigrant-workers Signed September 19, 2025; effective September 21, 2025. Imposes a $100,000 payment requirement on certain new H-1B petitions for beneficiaries outside the United States, with national-interest exemptions and a twelve-month sunset absent extension. ↩
16. U.S. Citizenship and Immigration Services. (2025). H-1B: Frequently asked questions on the September 2025 proclamation. https://www.uscis.gov/newsroom/alerts/h-1b-faq USCIS guidance that the payment requirement applies to new petitions for beneficiaries outside the United States without a valid H-1B visa, and does not reach previously issued visas, earlier-filed petitions, renewals, or change-of-status, amendment, and extension petitions for people already in the country. ↩
17. State of California v. Mullin, No. 1:25-cv-13829-LTS (D. Mass. June 8, 2026) (Sorokin, J.), appeal docketed, No. 26-01699 (1st Cir. 2026). https://www.fragomen.com/insights/united-states-district-court-temporarily-stays-order-vacating-dollar100000-h-1b-fee.html The district court vacated the payment requirement on June 8, 2026 as an unlawful tax and Administrative Procedure Act violation, then temporarily stayed its own order on June 12, 2026 pending appeal; the government appealed to the First Circuit. The requirement therefore remains operational for affected petitions at this writing. A fast-moving matter — verify current status before relying. ↩

Figures here are survey-, model-, and Match-based and shift year to year; there is no clean standalone sleep-medicine compensation figure, so pay is anchored to the base specialty and read directionally; the OSA-prevalence and treatment literature is moving quickly and partly industry-funded; and the visa landscape is in active flux and litigation. Verify against the primary source before relying on any single figure for a career, contract, or immigration decision. This page is educational and is not career, financial, immigration, or legal advice.